The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

AI can now create genome viruses in laboratories and redesign toxins to evade controls, raising biosafety alert and rise of ...

The fungal compound verticillin A, discovered more than 50 years ago, has long been regarded for its potential ...

Low levels of albumin, a protein found in blood, are associated with poor clinical outcomes for people with the fungal disease mucormycosis.

A Northwestern Medicine study has revealed a previously unknown connection between two fundamental cellular processes, ...

A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its ...

The immune system’s first encounter with a virus or vaccine establishes a “starting template” that shapes its response to new ...